Sibionics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
700
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$73M
- Investors
-
26
Sibionics General Information
Description
Manufacturer of a continuous glucose monitoring system designed for real-time health insights. The company offers calibration-free sensors, dual-spring applicators, waterproof monitoring, cloud data storage, and automated reporting, providing individuals with diabetes a way to track glucose levels for fourteen days without manual scanning or finger-pricking.
Contact Information
Website
www.sibionics.comCorporate Office
- Building 3, Tingwei Industrial Park
- Number 6 Liufang Road, Xingdong Community,Xin 'an Street, Bao'an District
- Shenzhen, Guangdong
- China
Corporate Office
- Building 3, Tingwei Industrial Park
- Number 6 Liufang Road, Xingdong Community,Xin 'an Street, Bao'an District
- Shenzhen, Guangdong
- China
Sibionics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series D) | 08-Sep-2022 | $73M | Completed | Generating Revenue | ||
| 9. Later Stage VC (Series C2) | 14-Jan-2022 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C1) | 07-May-2021 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 25-Dec-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 20-Aug-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B1) | 23-Jan-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 01-Jun-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 25-May-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 25-May-2016 | Completed | Generating Revenue | |||
| 1. Seed Round | 23-Dec-2015 | Completed | Startup |
Sibionics Signals
Sibionics Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| China New Town Development | Corporation | Minority | ||
| Guangdong Hengjian Investment | Venture Capital | Minority | ||
| Next Capital (China) | Venture Capital | Minority | ||
| Qianhai Infrastructure Fund | Infrastructure | Minority | ||
| Shanghai Healthcare Capital | PE/Buyout | Minority |
Sibionics Investments (1)
Sibionics’s most recent deal was a Later Stage VC with Singmed for . The deal was made on 19-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Singmed | 19-Jan-2026 | Later Stage VC | Therapeutic Devices |
Sibionics FAQs
-
When was Sibionics founded?
Sibionics was founded in 2015.
-
Where is Sibionics headquartered?
Sibionics is headquartered in Shenzhen, China.
-
What is the size of Sibionics?
Sibionics has 700 total employees.
-
What industry is Sibionics in?
Sibionics’s primary industry is Monitoring Equipment.
-
Is Sibionics a private or public company?
Sibionics is a Private company.
-
What is Sibionics’s current revenue?
The current revenue for Sibionics is .
-
How much funding has Sibionics raised over time?
Sibionics has raised $167M.
-
Who are Sibionics’s investors?
China New Town Development, Guangdong Hengjian Investment, Next Capital (China), Qianhai Infrastructure Fund, and Shanghai Healthcare Capital are 5 of 26 investors who have invested in Sibionics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process